Signaling Pathways - Insulin and Insulin-like Receptors - CysLT1 - CREBBP - c-MET
清除全部
-
B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂 -
B8031 MK-571 sodium salt hydrate3 CitationTarget: CysLT1Summary: CysLT1受体拮抗剂 -
A8448 INCB28060中文名: 苯扎米特Target: c-METSummary: C-Met抑制剂 -
A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂 -
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂 -
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2抑制剂 -
A2412 CP-724714Target: VEGFR|PDGFR|Bcr-Abl|Src|EGFR|c-MET|Insulin Receptors|IRG-1RSummary: 有效的HER2选择性抑制剂 -
A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂 -
A5096 PF-04217903Target: c-METSummary: C-Met的选择性和ATP竞争性抑制剂 -
A2307 PHA-6657521 CitationTarget: c-METSummary: c-Met的ATP竞争性、有效的、选择性抑制剂